Covington Capital Management Ensysce Biosciences, Inc. Transaction History
Covington Capital Management
- $23.2 Billion
- Q3 2022
A detailed history of Covington Capital Management transactions in Ensysce Biosciences, Inc. stock. As of the latest transaction made, Covington Capital Management holds 100 shares of ENSC stock, worth $65. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$65
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ENSC
# of Institutions
1Shares Held
100Call Options Held
0Put Options Held
0About Ensysce Biosciences, Inc.
- Ticker ENSC
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,918,900
- Market Cap $1.25M
- Description
- Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...